“…High rates of portal venopathy and nodular regenerative hyperplasia may contribute to portal hypertension, splenomegaly, and splenic sequestration (44). This latter point is noteworthy, because the decline in platelet count is linked to splenomegaly and is also a strong predictor of mortality in CGD (45). Chronic drug effects, liver enzyme elevations, and recurrent infections are obvious risks for liver dysfunction.…”